Correlation Between Visa and International Biotechnology

Can any of the company-specific risk be diversified away by investing in both Visa and International Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and International Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and International Biotechnology Trust, you can compare the effects of market volatilities on Visa and International Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of International Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and International Biotechnology.

Diversification Opportunities for Visa and International Biotechnology

0.67

Correlation Coefficient

Visa  International Biotechnology

Poor diversification

The 3 months correlation between Visa and International is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and International Biotechnology Tr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on International Biotechnology and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with International Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of International Biotechnology has no effect on the direction of Visa i.e., Visa and International Biotechnology go up and down completely randomly.

Pair Corralation between Visa and International Biotechnology

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.82 times more return on investment than International Biotechnology. However, Visa Class A is 1.22 times less risky than International Biotechnology. It trades about 0.09 of its potential returns per unit of risk. International Biotechnology Trust is currently generating about 0.02 per unit of risk. If you would invest  20,183  in Visa Class A on September 18, 2024 and sell it today you would earn a total of  11,406  from holding Visa Class A or generate 56.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.2%
Values	Daily Returns

Visa Class A  vs.  International Biotechnology Tr

Visa Class A

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in January 2025.

International Biotechnology

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in International Biotechnology Trust are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, International Biotechnology is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Visa and International Biotechnology

The main advantage of trading using opposite Visa and International Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, International Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International Biotechnology will offset losses from the drop in International Biotechnology's long position.

The idea behind Visa Class A and International Biotechnology Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.